title: Suppressor deletion therapy. Selective elimination of T suppressor cells using a hematoporphyrin-conjugated monoclonal antibody.
authors.affiliation: University of British Columbia, Vancouver, Canada.
authors.forename: J K
authors.initials: JK
authors.lastname: Steele
authors.forename: D
authors.initials: D
authors.lastname: Liu
authors.forename: A T
authors.initials: AT
authors.lastname: Stammers
authors.forename: H
authors.initials: H
authors.lastname: Deal
authors.forename: S
authors.initials: S
authors.lastname: Whitney
authors.forename: J G
authors.initials: JG
authors.lastname: Levy
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D006415:Hematoporphyrins / Q000494:pharmacology / Q000627:therapeutic use*; D007167:Immunotherapy; D000922:Immunotoxins / Q000627:therapeutic use*; D007942:Leukemia, Experimental / Q000628:therapy*; D008212:Lymphocyte Depletion / Q000379:methods*; D051379:Mice; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D006415:Hematoporphyrins; D000922:Immunotoxins